Business Description
Aion Therapeutic Inc
NAICS : 325411
SIC : 3741
ISIN : CA00905T1021
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | -3.33 | |||||
Debt-to-Equity | -0.62 | |||||
Debt-to-EBITDA | -0.41 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -49.77 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 35.3 | |||||
3-Year EPS without NRI Growth Rate | 69.1 | |||||
3-Year FCF Growth Rate | 57.1 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 24.07 | |||||
9-Day RSI | 32.04 | |||||
14-Day RSI | 37.29 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.2 | |||||
Quick Ratio | 0.1 | |||||
Cash Ratio | 0.02 | |||||
Days Inventory | 362.82 | |||||
Days Sales Outstanding | 15.78 | |||||
Days Payable | 1863.46 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -48.8 | |||||
Shareholder Yield % | -17.23 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 44.39 | |||||
Operating Margin % | -167.33 | |||||
Net Margin % | -789.15 | |||||
FCF Margin % | -144.01 | |||||
ROA % | -381.77 | |||||
ROIC % | -47.9 | |||||
ROC (Joel Greenblatt) % | -3674.85 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 5 | |||||
EV-to-EBIT | -1.18 | |||||
EV-to-EBITDA | -1.19 | |||||
EV-to-Revenue | 9.05 | |||||
EV-to-FCF | -10.47 | |||||
Earnings Yield (Greenblatt) % | -84.57 | |||||
FCF Yield % | -23.88 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Aion Therapeutic Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 0.802 | ||
EPS (TTM) (C$) | -0.016 | ||
Beta | -0.19 | ||
Volatility % | 136.52 | ||
14-Day RSI | 37.29 | ||
14-Day ATR (C$) | 0.002541 | ||
20-Day SMA (C$) | 0.017 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (C$) | 0.005 - 0.02 | ||
Shares Outstanding (Mil) | 483.55 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Aion Therapeutic Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Aion Therapeutic Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Aion Therapeutic Inc Frequently Asked Questions
What is Aion Therapeutic Inc(XCNQ:AION)'s stock price today?
When is next earnings date of Aion Therapeutic Inc(XCNQ:AION)?
Does Aion Therapeutic Inc(XCNQ:AION) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |